Coastline Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Coastline Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.4K	Hold	110	–	–	﹤0.01%	329
2026 Q1	$14.1K	Buy	110 +40	+57%	+$4.99K	﹤0.01%	338
2025 Q4	$8.54K	Buy	+70	New	+$8.03K	﹤0.01%	362
2016 Q1	–	Sell	-3,000	Closed	-$211K	–	262
2015 Q4	$211K	Buy	+3,000	New	+$205K	0.05%	253
2015 Q3	–	Sell	-3,000	Closed	-$252K	–	265
2015 Q2	$252K	Hold	3,000	–	–	0.05%	246
2015 Q1	$226K	Sell	3,000 -3,000	-50%	-$210K	0.05%	254
2014 Q4	$372K	Buy	+6,000	New	+$342K	0.08%	226

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Coastline Trust's XBI Position: Q2 2026 in Review

Coastline Trust held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 110 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #329.

Coastline Trust first reported a position in XBI in Q4 2014 and has held it in 7 quarters since. The position peaked at $372K in Q4 2014. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Coastline Trust held 110 shares of State Street SPDR S&P Biotech ETF worth $17.4K as of Q2 2026.
Coastline Trust left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Coastline Trust's portfolio in Q2 2026, its #329 holding.
Coastline Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and has held it in 7 quarters since.
Coastline Trust's State Street SPDR S&P Biotech ETF position peaked at $372K in Q4 2014.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Coastline Trust's 13F filing for Q2 2026, filed 14 Aug 2026.